Autologous Transplant vs. CAR-T Therapy in Patients with DLBCL Treated While in Complete Remission

0
41
Scientists compared the efficacy of autologous hematopoietic cell transplantation (auto-HCT) vs. CAR-T in patients with DLBCL in complete remission. A retrospective observational study comparing auto-HCT (2015–2021) vs. CAR-T using the Center for International Blood & Marrow Transplant Research registry.
[Blood Cancer Journal]
Abstract